
Biopharmaceutical company
Market Access Lead
必备技能
Market Access
Health Economics
Pricing Strategy
Reimbursement
Stakeholder Management
Portuguese
English
Microsoft Office
At Gilead, we’re creating a healthier world for all people. For more than 35 years, we’ve tackled diseases such as HIV, viral hepatitis, COVID-19 and cancer – working relentlessly to develop therapies that help improve lives and to ensure access to these therapies across the globe. We continue to fight against the world’s biggest health challenges, and our mission requires collaboration, determination and a relentless drive to make a difference.
Every member of Gilead’s team plays a critical role in the discovery and development of life-changing scientific innovations. Our employees are our greatest asset as we work to achieve our bold ambitions, and we’re looking for the next wave of passionate and ambitious people ready to make a direct impact.
We believe every employee deserves a great leader. People Leaders are the cornerstone to the employee experience at Gilead and Kite. As a people leader now or in the future, you are the key driver in evolving our culture and creating an environment where every employee feels included, developed and empowered to fulfil their aspirations. Join Gilead and help create possible, together.
Job Description Job Description The Brazil Market Access team is expanding with a new and exciting opportunity for a Market Access Lead – Cell Therapy.
This position will be primarily based at the São Paulo office and will report to the Associate Director of Market Access.
The responsibilities of this role include the development and execution of pricing and access/reimbursement strategies, as well as the creation of compelling value propositions that integrate clinical and economic evidence for payers. In addition, the role will work in close alignment with cross‑functional teams at Gilead/Kite to ensure cohesive planning and delivery.
The flexibility of the organization and the evolving product portfolio of Gilead/Kite also mean that the scope of this position may further develop and broaden over time, providing additional opportunities for professional growth.
Responsibilities & Accountabilities:
· Develop strategies for the private market and hospitals, shaping the access environment and ensuring CAR‑T reimbursement in close collaboration with internal and external stakeholders.
· Contribute to the development and assessment of pricing strategies, ensuring alignment with brand and access objectives.
· Support the implementation of access strategies, understanding payer archetypes and regional needs, and tailoring approaches accordingly.
· Collaborate with the Key Account team to develop compelling value propositions and appropriate tools that enable access solutions benefiting both patients and Gilead/Kite therapies.
· Support Key Account Managers in field activities, providing guidance on access-related topics and payer engagement.
· Partner with the Medical team to identify evidence-generation needs focused on reimbursement requirements (GAP assessments, HTA needs, and alignment with country objectives).
· Ensure training on payer‑relevant materials—including product value proposition, evidence, tools, and the value story—for both the team and cross‑functional partners.
· Leverage market and account intelligence to identify, segment, profile, and define key accounts.
· Lead the preparation and submission of reimbursement dossiers required by regional-level stakeholders, hospitals, payers, and other health decision-makers.
· Support the establishment and monitoring of KPIs related to access strategies.
· Build strong working relationships with cross‑functional teams, providing strategic input for brand strategy development and ensuring cohesive execution of plans.
· Anticipate and communicate cross‑functional impacts of changes in the payer environment to enrich the brand team’s strategic planning.
· Identify opportunities and collaborate cross‑functionally to develop “win–win” partnerships with traditional and non‑traditional stakeholders that positively influence product access.
· Manage the CAR‑T Market Access budget, ensuring optimal allocation of resources and maximizing return on investment for proposed initiatives.
· Ensure full compliance with the Business Conduct Manual, as well as all relevant external regulations and policies applicable to this role.
Ideally, the successful applicant should have the following:
-
Robust and demonstrable experience in developing, implementing and delivery of market access and health economic strategies and materials
-
Solid understanding of Market Access processes and payer needs and strategies at national, regional and local level
-
Affinity and understanding of pricing dynamics that impact the Gilead Kite portfolio
-
Demonstrates accountability, a mindset that works through uncertainty, delivers to expectations and exhibits a sense of urgency on critical time-dependent issues
-
Capability to network, build strong and credible relationships with internal colleagues and payer stakeholders
-
Strong teamwork and facilitation, effective working in matrix environment and managing cross functional responsibilities
-
Driven & proactive with strong analytical skills to lead CAR-T access initiatives
-
Flexibility and growth mindset to take on new challenges within the Market Access team
-
Specific education and experience requirements
-
At least 5 years’ experience in Market Access, ideally with a proven record of gaining broader access for new medication
-
Excellent communications skills in Portuguese and English (oral and written) to be able to present recommendations at affiliate leadership and above
-
country level
-
Competent experience of using Microsoft Office products is required
-
Previous experience in working on oncology products will be preferred
-
Previous experience in access field-based positions will be a differential
Gilead core values
Integrity (doing what's right)
Teamwork (working together)
Excellence (being your best)
Accountability (taking personal responsibility)
Inclusion (encouraging diversity)
- Grade 28-29
- Location: São Paulo-SP / Brazil
- Hydrid (office/ field)
For Current Gilead Employees and Contractors:
Please apply via the Internal Career Opportunities portal in Workday.
浏览量
0
申请点击
0
Mock Apply
0
收藏
0
相似职位

EPC / Construction Project Controls Internship (m/f/d) - Gigafactory Berlin-Brandenburg
Tesla · Grünheide (mark), Brandenburg

Vehicle Service Technician, Parramatta
Tesla · Parramatta, New South Wales

Delivery Advisor
Tesla · Alcobendas, Md

Purchasing Lead, Cell Project Engineering
Tesla · Austin, Texas

Service Technician
Tesla · Gainesville, Florida
关于Gilead Sciences

Gilead Sciences
PublicGilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir.
10,001+
员工数
Foster City
总部位置
$85B
企业估值
评价
10条评价
3.7
10条评价
工作生活平衡
2.8
薪酬
4.2
企业文化
3.1
职业发展
3.4
管理层
2.5
65%
推荐率
优点
Good people and friendly colleagues
Competitive compensation and benefits
Career growth opportunities
缺点
Management issues and difficult leadership
Poor work-life balance
Toxic culture and workplace stress
薪资范围
44个数据点
Junior/L3
Mid/L4
Senior
Director
Junior/L3 · Program Manager
0份报告
$212,000
年薪总额
基本工资
-
股票
-
奖金
-
$180,200
$244,000
面试评价
42条评价
难度
3.2
/ 5
时长
14-28周
录用率
41%
体验
正面 64%
中性 21%
负面 15%
面试流程
1
Phone Screen
2
Technical Interview
3
Hiring Manager
4
Team Fit
常见问题
Technical skills
Past experience
Team collaboration
Problem solving
最新动态
Wilson Sonsini Advises Arcellx on Merger with Gilead Sciences - Wilson Sonsini
Wilson Sonsini
News
·
1w ago
Gilead Sciences Crosses Critical Breakout Level. The Stock Can Gain 35% From Here. - Barron's
Barron's
News
·
1w ago
Gilead Sciences completes acquisition of Arcellx ahead of potential commercial launch of Anito-cel - marketscreener.com
marketscreener.com
News
·
1w ago
Gilead Completes $7.8 Billion Acquisition of Arcellx - Contract Pharma
Contract Pharma
News
·
1w ago